Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Using Epidemiologic Methods to Advance Comparative Effectiveness Research

Session Chair(s)

Nancy A Dreyer, PhD, MPH, FISPE

Nancy A Dreyer, PhD, MPH, FISPE

Founder

Dreyer Strategies LLC, United States

The strengths and limitations of observational studies of comparative effectiveness research will be presented, along with a discussion of epidemiologic methods, resources, and a validated scale for assessing observational study quality.

Learning Objective : Describe the use of knowledge about using epidemiologic methods for comparative effectiveness research; Discuss pros and cons of using observational methods to support comparative effectiveness research; Explain resources available to assist in understanding epidemiologic methods and evaluating studies.

Speaker(s)

Kenneth J. Rothman, DrPH, FISPE

Science Beyond the Randomized Trial

Kenneth J. Rothman, DrPH, FISPE

RTI Health Solutions, United States

Distinguished Fellow

Nancy A Dreyer, PhD, MPH, FISPE

GRACE Checklist for Observational Studies of Comparative Effectiveness Research

Nancy A Dreyer, PhD, MPH, FISPE

Dreyer Strategies LLC, United States

Founder

Hans-Georg  Eichler, MD, MSc

(How) Can Regulators Support CER?

Hans-Georg Eichler, MD, MSc

Austrian Association of Social Security Bodies, Austria

Consulting Physician

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.